[HTML][HTML] Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions
Objective Risk factors for in-hospital mortality in confirmed COVID-19 patients have been
summarized in numerous meta-analyses, but it is still unclear whether they vary according to …
summarized in numerous meta-analyses, but it is still unclear whether they vary according to …
[HTML][HTML] Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
M Treskova-Schwarzbach, L Haas, S Reda, A Pilic… - BMC medicine, 2021 - Springer
Background This study applies an umbrella review approach to summarise the global
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases
PJ Thuluvath, P Robarts, M Chauhan - Journal of hepatology, 2021 - Elsevier
Background & Aims Liver transplant (LT) recipients or other immunocompromised patients
were not included in the registration trials studying the efficacy of vaccines against SARS …
were not included in the registration trials studying the efficacy of vaccines against SARS …
[HTML][HTML] COVID-19 vaccine hesitancy and acceptance among individuals with cancer, autoimmune diseases, or other serious comorbid conditions: cross-sectional …
R Tsai, J Hervey, K Hoffman, J Wood… - JMIR public health …, 2022 - publichealth.jmir.org
Background: Individuals with comorbid conditions have been disproportionately affected by
COVID-19. Since regulatory trials of COVID-19 vaccines excluded those with …
COVID-19. Since regulatory trials of COVID-19 vaccines excluded those with …
[HTML][HTML] COVID-19: Why does disease severity vary among individuals?
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
responsible for the current pandemic, coronavirus disease 2019 (COVID-19). While all …
responsible for the current pandemic, coronavirus disease 2019 (COVID-19). While all …
[HTML][HTML] Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors
T Yin, Y Li, Y Ying, Z Luo - BMC infectious diseases, 2021 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is an infectious disease
characterized by cough, fever, and fatigue and 20% of cases will develop into severe …
characterized by cough, fever, and fatigue and 20% of cases will develop into severe …
[HTML][HTML] Metabolic associated fatty liver disease is associated with an increased risk of severe COVID-19: a systematic review with meta-analysis
Background: The most common pre-existing liver disease, the metabolic dysfunction-
associated fatty liver disease (MAFLD) formerly named as non-alcoholic fatty liver disease …
associated fatty liver disease (MAFLD) formerly named as non-alcoholic fatty liver disease …
[HTML][HTML] Who should be prioritized for COVID-19 vaccination in China? A descriptive study
J Yang, W Zheng, H Shi, X Yan, K Dong, Q You… - BMC medicine, 2021 - Springer
Background All countries are facing decisions about which population groups to prioritize for
access to COVID-19 vaccination after the first vaccine products have been licensed, at which …
access to COVID-19 vaccination after the first vaccine products have been licensed, at which …
[HTML][HTML] 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association - Korean Journal of Radiology, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …
[HTML][HTML] COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
Methods We collected data via three databases from inception to February 16, 2022, and
reported pooled seroconversion rate, T cell response and safety data after two vaccine …
reported pooled seroconversion rate, T cell response and safety data after two vaccine …